Arca Biopharma | ABIO - Capital Ordinário





Capital Ordinário Alterar Data
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Amgen USD 541M 1000K 2026-06
Arca Biopharma USD 50.17M 1.45M 2026-03
Biogen USD 146.7M 200K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 0 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Cipla INR 807.78M 17K 2026-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1000 2026-03
CSL USD 482.13M 93.87M 2025-12
Cytokinetics USD 124.43M 2.17M 2026-03
Daiichi Sankyo JPY 1.82B 30.68M 2026-06
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Grifols EUR 680.58M 846.11K 2025-12
Laboratory Of America USD 80.9M 1.4M 2026-06
Myriad Genetics USD 93.5M 400K 2025-12
Otsuka Holdings JPY 525.39M 1.91M 2026-06
Pfizer USD 5.7B 0 2026-06
United Therapeutics USD 42.68M 521K 2026-06